Indee Labs logo

Indee Labs

Enabling T cell immunotherapy discovery, development and manufacturing

Winter 2017Healthcare / Healthcare -> Drug Discovery and DeliveryBerkeley, CA, USA5 employees
Gene Therapy
Microfluidics
Cell Therapy

About

Intracellular delivery is the most problematic step in T cell immunotherapy discovery, development and manufacturing. Indee Labs is developing a non-viral intracellular delivery system based on microfluidic vortex shedding (µVS) to rapidly deliver nucleic acids, proteins and gene editing complexes to patient and donor T cells with minimal perturbation.

Founders (1)

Ryan Pawell
Founder/CEO

Details

Status
Active
Stage
Early
Team Size
5
Regions
United States of America, America / Canada, Remote, Partly Remote